share_log

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K:重大事件
美股SEC公告 ·  2024/11/21 13:22

Moomoo AI 已提取核心訊息

MIRA Pharmaceuticals announced that Michael Jerman has resigned from his position as Board member and Audit Committee Chair effective November 18, 2024, citing his desire to pursue other activities. The resignation was not due to any disagreements with the company.Matthew Pratt Whalen, CPA, has been appointed as the new Board member and Chairman of the Audit Committee. Whalen, 45, brings over two decades of experience in public accounting and corporate finance. He currently serves as CFO of Power Digital Marketing Inc. and as a director at Telmoir Pharmaceuticals. Previously, he held the CFO position at MRC Smart Technology Solutions, a Xerox subsidiary, from 2010 to 2021.
MIRA Pharmaceuticals announced that Michael Jerman has resigned from his position as Board member and Audit Committee Chair effective November 18, 2024, citing his desire to pursue other activities. The resignation was not due to any disagreements with the company.Matthew Pratt Whalen, CPA, has been appointed as the new Board member and Chairman of the Audit Committee. Whalen, 45, brings over two decades of experience in public accounting and corporate finance. He currently serves as CFO of Power Digital Marketing Inc. and as a director at Telmoir Pharmaceuticals. Previously, he held the CFO position at MRC Smart Technology Solutions, a Xerox subsidiary, from 2010 to 2021.
MIRA製藥公司宣佈,邁克爾·傑曼已於2024年11月18日辭去董事會成員及審計委員會主席職務,理由是他希望追求其他活動。辭職並不是由於與公司存在任何分歧。馬修·普拉特·韋倫,註冊會計師,已被任命爲新的董事會成員及審計委員會主席。韋倫,45歲,擁有超過二十年的公共會計和企業財務經驗。他目前擔任Power Digital Marketing Inc.的財務長,並在Telmoir Pharmaceuticals擔任董事。此前,他曾在2010年至2021年期間擔任施樂子公司MRC智能科技解決方案的財務長。
MIRA製藥公司宣佈,邁克爾·傑曼已於2024年11月18日辭去董事會成員及審計委員會主席職務,理由是他希望追求其他活動。辭職並不是由於與公司存在任何分歧。馬修·普拉特·韋倫,註冊會計師,已被任命爲新的董事會成員及審計委員會主席。韋倫,45歲,擁有超過二十年的公共會計和企業財務經驗。他目前擔任Power Digital Marketing Inc.的財務長,並在Telmoir Pharmaceuticals擔任董事。此前,他曾在2010年至2021年期間擔任施樂子公司MRC智能科技解決方案的財務長。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息